Prevalence of prescribed opioid claims among persons with nontraumatic spinal cord dysfunction in Ontario, Canada: a population-based retrospective cohort study.
Journal
Spinal cord
ISSN: 1476-5624
Titre abrégé: Spinal Cord
Pays: England
ID NLM: 9609749
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
18
08
2020
accepted:
01
12
2020
revised:
30
11
2020
pubmed:
27
1
2021
medline:
16
10
2021
entrez:
26
1
2021
Statut:
ppublish
Résumé
Cohort study. To determine the prevalence and to identify predictors of prescription opioid use among persons with nontraumatic spinal cord dysfunction within 1 year after discharge from inpatient rehabilitation. Ontario, Canada. We conducted a retrospective cohort study using administrative data to determine predictors of receiving prescription opioids during the 1 year after discharge from inpatient rehabilitation among persons with nontraumatic spinal cord dysfunction between April 1, 2004 and March 31, 2015. We modeled the outcome using a Poisson multivariable regression and reported relative risks with 95% confidence intervals. We identified 3468 individuals with nontraumatic spinal cord dysfunction (50% male) with 67% who were aged ≥66. Over half of the cohort (60%) received opioids during the observation period. Older adults (≥66 years old) were significantly more likely to experience comorbidities (p < 0.05) but less likely to be dispensed opioids following rehabilitation discharge. Being female, previous opioid use before rehabilitation, experiencing lower continuity of care, increasing comorbidity level, low functional status, and having a previous diagnosis of osteoarthritis or mental illness were significant risk factors for receiving opioids after discharge, as shown in a multivariable analysis. Increasing length of rehabilitation stay and higher income were protective against opioid receipt after discharge. Many individuals with nontraumatic spinal cord dysfunction in Ontario are prescribed opioids after discharge from inpatient rehabilitation. This may be problematic due to the number of severe complications that may arise from opioid use and their use in this population warrants future research.
Identifiants
pubmed: 33495578
doi: 10.1038/s41393-020-00605-1
pii: 10.1038/s41393-020-00605-1
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
512-519Références
Cadel L, DeLuca C, Hitzig SL, Packer TL, Lofters AK, Patel T, et al. Self-management of pain and depression in adultswith spinal cord injury: A scoping review. J Spinal Cord Med. 2020;43:280–97.
doi: 10.1080/10790268.2018.1523776
Guy SD, Mehta S, Casalino A, Côté I, Kras-Dupuis A, Moulin DE, et al. The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord: recommendations for treatment. Spinal Cord. 2016;54:S14–23.
doi: 10.1038/sc.2016.90
Hadjipavlou G, Cortese AM, Ramaswamy B. Spinal cord injury and chronic pain. BJA Educ. 2016;16:264–8.
doi: 10.1093/bjaed/mkv073
Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686–91.
pubmed: 21482846
Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173:196.
doi: 10.1001/2013.jamainternmed.733
Gomes T, Greaves S, Martins D, Bandola D, Tadrous M, Singh S, et al. Latest trends in opioid-related deaths in Ontario: 1991 to 2015. Ont Drug Policy Res Netw. 2017. http://odprn.ca/wp-content/uploads/2017/04/ODPRN-Report_Latest-trends-in-opioid-related-deaths.pdf .
Guilcher SJT, Munce SEP, Couris CM, Fung K, Craven BC, Verrier M, et al. Health care utilization in non-traumatic and traumatic spinal cord injury: a population-based study. Spinal Cord. 2010;48:45–50.
doi: 10.1038/sc.2009.78
Guilcher SJT, Voth J, Ho C, Noonan VK, McKenzie N, Thorogood NP, et al. Characteristics of non-traumatic spinal cord dysfunction in Canada using administrative health data. Top Spinal Cord Inj Rehabil. 2017;23:343–52.
doi: 10.1310/sci2304-343
Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound [Internet]. The King’s Fund; 2013. p. 1–4. Available from: https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf .
Hand BN, Krause JS, Simpson KN. Dose and duration of opioid use in propensity score–matched, privately insured opioid users with and without spinal cord injury. Arch Phys Med Rehabil. 2018;99:855–61.
doi: 10.1016/j.apmr.2017.12.004
Alam A, Juurlink DN. The prescription opioid epidemic: an overview for anesthesiologists. Can J Anesth. 2016;63:61–8.
doi: 10.1007/s12630-015-0520-y
Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. Can Med Assoc J. 2017;189:E659–66.
doi: 10.1503/cmaj.170363
Ge L, Arul K, Ikpeze T, Baldwin A, Nickels JL, Mesfin A. Traumatic and nontraumatic spinal cord injuries. World Neurosurg. 2018;111:e142–8.
doi: 10.1016/j.wneu.2017.12.008
Statistics Canada. Table 17-10-0009-01 Population estimates, quarterly. https://doi.org/10.25318/1710000901-eng .
Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Juurlink DN, et al. Self-monitoring of blood glucose levels: evaluating the impact of a policy of quantity limits on test-strip use and costs. Can J Diabetes. 2016;40:431–5.
doi: 10.1016/j.jcjd.2016.03.003
Cressman AM, Macdonald EM, Huang A, Gomes T, Paterson MJ, Kurdyak PA, et al. Prescription stimulant use and hospitalization for psychosis or mania: a population-based study. J Clin Psychopharmacol. 2015;35:667–71.
doi: 10.1097/JCP.0000000000000406
Bronskill SE, Campitelli MA, Iaboni A, Herrmann N, Guan J, Maclagan LC, et al. Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study. J Am Geriatr Soc. 2018;66:1963–71.
doi: 10.1111/jgs.15519
Ackroyd-Stolarz S, Bowles S, Giffin L. Validating administrative data for the detection of adverse events in older hospitalized patients. Drug Healthc Patient Saf. 2014;6:101–8.
doi: 10.2147/DHPS.S64359
Levy AR, O’Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67–71.
pubmed: 12879144
Steele LS, Glazier RH, Lin E, Evans M. Using administrative data to measure ambulatory mental health service provision in primary care. Med Care. 2004;42:960–5.
doi: 10.1097/00005650-200410000-00004
Guilcher SJT, Hogan M-E, McCormack D, Calzavara AJ, Hitzig SL, Patel T, et al. Prescription medications dispensed following a nontraumatic spinal cord dysfunction: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2020. http://www.nature.com/articles/s41393-020-0511-x .
Hanley GE, Morgan S, Reid RJ. Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada. Med Care. 2010;48:402–8.
doi: 10.1097/MLR.0b013e3181ca3d5d
Guilcher SJT, Hogan M-E, Guan Q, McCormack D, Calzavara A, Patel T, et al. Prevalence of prescribed opioid claims among persons with traumatic spinal cord injury in Ontario, Canada: a population-based retrospective cohort study. Arch Phys Med Rehabil. 2020. (In Press). https://doi.org/10.1016/j.apmr.2020.06.020 .
Jaglal SB, Voth J, Guilcher SJT, Ho C, Noonan VK, McKenzie N, et al. Creation of an algorithm to identify non-traumatic spinal cord dysfunction patients in Canada using administrative health data. Top Spinal Cord Inj Rehabil. 2017;23:324–32.
doi: 10.1310/sci2304-324
Koné Pefoyo AJ, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15:415.
doi: 10.1186/s12889-015-1733-2
Chehata VJ, Shatzer M, Cristian A. Chapter 3—Inpatient rehabilitation outcome measures in persons with brain and spinal cord cancer. In: Central nervous system cancer rehabilitation. St. Louis, Missouri, USA: Elsevier; 2019.
New PW, Eriks-Hoogland I, Scivoletto G, Reeves RK, Townson A, Marshall R, et al. Important clinical rehabilitation principles unique to people with non-traumatic spinal cord dysfunction. Top Spinal Cord Inj Rehabil. 2017;23:299–312.
doi: 10.1310/sci2304-299
CIHI. Canadian Institute for Health Information: opioid prescribing in Canada: how are practices changing? 2019. https://www.cihi.ca/sites/default/files/document/opioid-prescribing-canada-trends-en-web.pdf .
American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67:674–94.
doi: 10.1111/jgs.15767
Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ. 2018;29:k3207.
doi: 10.1136/bmj.k3207
Scherrer JF, Salas J, Copeland LA, Stock EM, Schneider FD, Sullivan M, et al. Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17:473–82.
doi: 10.1016/j.jpain.2015.12.012
New PW, Marshall R. International spinal cord injury data sets for non-traumatic spinal cord injury. Spinal Cord. 2014;52:123–32.
doi: 10.1038/sc.2012.160